International Nutrition Research Inc.

Winnipeg, Canada

International Nutrition Research Inc.

Winnipeg, Canada
SEARCH FILTERS
Time filter
Source Type

The invention relates to the use as a drug or medical nutritional product in humans to treat a pathological dysbiosis and/or to prevent or treat at least one derived metabolic disease chosen from among excess weight with comorbidity, obesity, diabetes, heart and vascular diseases, atherosclerosis, degenerative bone disease, neurodegenerative disease, metabolism-related cancers, autoimmune diseases, steatosis, metabolic steatohepatitis, and chronic inflammatory diseases of the intestine, by increasing the Christensenella bacterial genus in the intestine, of a composition comprising a mixture of active ingredients consisting of at least:


Surendiran G.,University of Manitoba | Alsaif M.,University of Manitoba | Kapourchali F.R.,International Nutrition Research Inc. | Moghadasian M.H.,University of Manitoba | Moghadasian M.H.,International Nutrition Research Inc.
Nutrition Reviews | Year: 2014

Wild rice (Zizania spp.) seems to have originated in North America and then dispersed into Eastern Asia and other parts of the world. Nutritional analysis shows that wild rice is rich in minerals, vitamins, protein, starch, dietary fiber, and various antioxidant phytochemicals, while it is low in fat. Wild rice has been recognized as a whole grain by the US Food and Drug Administration; in the North American marketplace it is currently sold as and considered to be a health-promoting food. Recent scientific studies have revealed antioxidant and lipid-lowering properties of wild rice, while others have documented cardiovascular benefits associated with the long-term consumption of wild rice in experimental settings. The present review article summarizes various features of wild rice and its cultivation, including its plantation, harvest, nutritional composition, and biological properties. While evidence for the cardiovascular benefits of wild rice consumption is accumulating, additional studies are warranted to determine the clinical benefits of regular consumption of wild rice. © 2014 International Life Sciences Institute.


The invention relates to the use as a drug or medical nutritional product in humans to treat a pathological dysbiosis and/or to prevent or treat at least one derived metabolic disease chosen from among excess weight with comorbidity, obesity, diabetes, heart and vascular diseases, atherosclerosis, degenerative bone disease, neurodegenerative disease, metabolism-related cancers, autoimmune diseases, steatosis, metabolic steatohepatitis, and chronic inflammatory diseases of the intestine, by increasing the Christensenella bacterial genus in the intestine, of a composition comprising a mixture of active ingredients consisting of at least:


A composition suitable for use as a health product, including a mixture of active ingredients made up of at least: a lactoserum hydrolysate with a molecular weight between 200 and 5000 daltons, alpha-lactalbumin, at least one AMPK, MAPK, PPAR and/or SIRT1 cycle regulator, and milk calcium. The composition is particularly useful as a medical nutrition product or orally administered drug, to prevent and/or combat various diseases.


An orally administered dietary product intended to reduce an obese persons visceral fat during the pre-operative phase prior to bariatric surgery, the product includes in particular a mixture of: a whey hydrolysate having a molecular weight of between 200 and 10,000 daltons, an isolate and/or a concentrate of whey, and calcium caseinate.


Patent
International Nutrition Research Company | Date: 2015-03-18

The invention relates to an orally administered drug or medical nutrition composition for use in the prevention or treatment of metabolic steatosis and steatohepatitis of abdominally obese people with metabolic syndrome. The composition comprises at least:


A composition for oral administration in humans comprising at least one plant protein chosen from pea proteins, rice proteins or a mixture thereof, and:


Trademark
International Nutrition Research Company | Date: 2013-11-11

Beverages adapted for medical purposes; Dietetic beverages adapted for medical purposes; Beverages based on milk for medical purposes; Foods and dietetic substances adapted for medical use; Nutritional and dietetic food supplements.


Patent
International Nutrition Research Company | Date: 2012-10-25

A dietary product for preventing cardiometabolic risk in humans, in particular for reducing visceral fat and deep subcutaneous fat, includes in particular a mixture of: a whey hydrolysate having a molecular weight of between 200 and 10,000 daltons, an isolate and/or concentrate of whey, and calcium caseinate.


Trademark
International Nutrition Research Company | Date: 2013-01-03

Dietetic foods, namely, powders, bars, cookies, crackers and sugar substitutes adapted for medical or veterinary use; dietary supplements for humans and animals adapted for medical use.

Loading International Nutrition Research Inc. collaborators
Loading International Nutrition Research Inc. collaborators